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TO THE EDITOR
Atopic dermatitis (AD) represents an
inﬂammatory, relapsing, non-conta-
gious, and itchy skin disorder affecting
up to 30% of children and 2–10%
of adults in industrialized countries
(Bieber, 2008). It is well established
that allergen-speciﬁc T cells display a
Th2 polarization in allergic donors
(Bateman et al., 2006; Macaubas
et al., 2006; Wambre et al., 2008)
with a tendency to develop into Th1
in chronic AD (Thepen et al., 1996;
Werfel et al., 1996). The high
proportion of Th2-polarized T cells
seems to be the key factor in allergic
inﬂammation (Werfel, 2009), and
allergen-speciﬁc Th2 cells are reduced
after successful speciﬁc immunotherapy
(Wambre et al., 2012; Wambre et al.,
2014). However, the classical paradigm
of a Th2-polarized allergen-speciﬁc T
cell has been questioned, as Th17 and
Th22 polarizations have been described
in allergic diseases (Aggarwal et al.,
2003; Langrish et al., 2005; Eyerich
et al., 2009). Especially, the responses
to house dust mite (HDM) allergens differ
between atopic diseases. Although in
allergic asthma this seems to be
inﬂuenced by lipopolysaccharide (LPS)-
toll-like receptor4 (TLR4) signaling, in
allergic rhinitis TLR2 responses may
rather have a role (Ryu et al., 2013).
High-titered HDM-speciﬁc IgE can
be detected particularly often in older
children, adolescents, and adults
with AD. This study aimed to charac-
terize Dermatophagoides pteronyssinus
(Der p)-1– and Der p2–speciﬁc T-helper
cells in patients suffering from AD.
Thirty adult consecutive patients with
AD fulﬁlling the criteria of Haniﬁn
and Rajka (Haniﬁn and Rajka, 1980)
from our Department who were IgE
sensitized to HDM were included in
this study. These showed various IgE
sensitizations and a mild-to-severe dis-
ease activity (scoring atopic dermatitis
(SCORAD) 2.5–70.5; mean 33.4, see
Supplementary Table S1). Median CAP
class of our patient cohort was class 5
(D. pteronyssinus) and class 4 (Der p1
and Der p2), respectively. One further
AD patient was included who sufferedAccepted article preview online 28 April 2015; published online 28 May 2015
Abbreviations: AD, atopic dermatitis; Der p, Dermatophagoides pteronyssinus; HDM, house dust mite;
LPS, lipopolysaccharide; MHC, major histocompatibility complex; PBMC, peripheral blood
mononuclear cell; SCORAD, scoring atopic dermatitis; TLR, toll-like receptor
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from the intrinsic variant. Three non-
atopic healthy individuals served as
controls.
Regarding the investigation of antigen-
speciﬁc T cells, the major histo-
compatibility complex (MHC) multimer-
technology represents the state-of-the-art
in detection and characterization of
cells directly ex vivo. HLA-DRB1*1501
Der p116-30, Der p1171-185, and Der
p226-40 MHC class II tetramers used in
this study had already been applied in
patients with allergic rhinitis and showed
speciﬁc staining to freshly isolated lym-
phocytes in peripheral blood mononuc-
lear cell (PBMC) fractions in every third
HLA-matched patient and in a frequency
of 1–2 in 40.000 CD4+ T cells (Wambre
et al., 2011). In our study, of all 31 AD
patients, 18 matched the HLA-type of
the tetramers. The three non-atopic,
healthy individuals of this study were
selected as appropriate controls, as they
also matched the wanted HLA-type
HLA-DRB1*1501.
To gain detectable amounts of
allergen-speciﬁc cells from PBMCs
without pre-ampliﬁcation generating
cell culture artifacts, we applied
magnetic-bead enrichment of tetramer-
binding cells as described earlier
(Day et al., 2003). Subsequently,
every single tetramer-positive cell was
stained by Chipcytometry (Hennig
et al., 2009), with a series of markers
and a vital stain inside a microﬂuidic
chip (Figure 1a). This imaging technique
bears advantages over ﬂow cytometry
whenever a large set of markers shall
be assessed on a small number of
cells. Detailed information about
methods and control experiments can
be found in the Supplementary Infor-
mation online.
Speciﬁc staining was detected in six
out of 18 HLA-matched individuals
(Figure 1b). Of all the polarized T cells
detected, 38.5% showed the Th2 marker
pattern (CD3+/CD4+/CRTh2+/CCR6−/IL-
-18R−), 23.1% displayed the Th17 surface
markers (CD3+/CD4+/CRTh2−/CCR6+/IL-
-18R−), and 19.2% a mixed Th2/Th17
phenotype (CD3+/CD4+/CRTh2+/CCR6+/
IL-18R−). Furthermore, a single cell
(3.8%) with a Th1 marker pattern (CD3+
/CD4+/CRTh2−/CCR6−/IL-18R+) as well
as four cells (15.4%) with other combina-
tions of markers was observed (Figure 1b).
All of these cells displayed an effec-
tor/memory phenotype (CD45RA−/
CD45R0+/CD27−) with the exception
of the single Th1-polarized cell, which
displayed the memory T–cell marker set
(CD45RA−/CD45R0+/CD27+). The intrin-
sic patient showed one tetramer-positive
cell, which turned out to be a naive T cell
(as shown in Figure 1a, CD45RA+/
CD45R0−/CD27+). In HLA-matched,
healthy control individuals no tetramer-
positive T cells were detectable.
Patients with detectable tetramer+
T-helper cells showed a signiﬁcantly
higher median SCORAD but a compar-
able IgE-sensitization pattern compared
with those without detectable tetramer+
T cells (Supplementary Figure S1 online).
As all patients of the tetramer+ group
have been investigated in our clinical
department several times, the value of
the SCORAD depicted here reﬂects a
chronic moderate to severe course of AD
and not an incidental ﬂare-up. On the
one hand this may suggest that, despite
the small size of the cohort, the presence
of tetramer+ T cells in the blood reﬂects
the disease severity. On the other hand,
this observation indicates that the pre-
sence of tetramer+ T cells is more prob-
able in those individuals suffering from
more severe AD.
To elucidate whether the T-cell
phenotypes identiﬁed by surface marker
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Figure 1. Tetramer+ T cells were analyzed for the expression of surface markers as indicated and
assigned to the corresponding polarization states. (a) Representative cells. HDM-tetramer, vital stain, and
eight surface markers were analyzed per cell. TL, transmitted light. (b) Polarization pattern of HDM-
speciﬁc T-helper cells identiﬁed. Cells expressed CRTh2 (n=10/26), CCR6 (n=6/26), both CRTh2 and
CCR6 (n=5/26), IL-18-R (n=1/26), or another combination of these (n=4/26) as indicated by the colors,
or no polarization markers (not shown). Patient/cell numbers below the bars correspond to patient
numbers in Supplementary Table S1 online. TL, transmitted light.
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analysis lead to the corresponding Th2/
Th17 cytokine milieu, we analyzed
secreted cytokines in cell culture super-
natants of T-cell lines (TCL) from 26
HDM-sensitized AD patients, which
were generated in the presence of Der
p1 and Der p2, respectively. Only T-cell
lines with proliferative capacity upon
re-stimulation with the antigen assessed
by 3H-thymidine uptake were regarded
as speciﬁc. Successful proliferation of
Der p1– and Der p2–speciﬁc cells in the
TCL could also be observed by a shift
toward CD4+ content of the cultures
(Figure 2a). Incubation with these anti-
gens led to increased amounts of
secreted IL-4, IL-17, and IL-22, whereas
IL-9 and IFN-γ production was not
affected (Figure 2b). This effect was
observed for both allergens but not in
LPS-control experiments (Supplementary
Figure S2 online). TCL without Der p1– or
Der p2–speciﬁc proliferative capacity
served as controls. Here, no increased
cytokine secretion after allergen incuba-
tion was detectable (Figure 2c). We
therefore conclude that HDM-speciﬁc
T cells might be the cytokine source,
although we cannot exclude that bystan-
der cells activated by speciﬁc T cells
contributed to the results obtained by this
approach. Our data mirror results from
other allergic diseases, as a Th2/Th17
double-positive subfraction of human
T-helper cells was detected in allergic
rhinitis and asthma (Cosmi et al., 2010;
Wang et al., 2010; Wambre et al., 2011).
Probably, the Th17 polarization occurs
due to microbial compounds like LPS,
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Figure 2. T-cell lines generated from D. pteronyssinus-sensitized patients with AD in the absence (n.s.) or presence of the antigen (Der p1 and Der p2,
respectively). (a) Proportion of CD4+ cells was increased within the T-cell lines generated in the presence of Der p allergens. (b) Cytokine production pattern of
T-cell lines that showed Der p1– and Der p2–speciﬁc proliferative capacities were intraindividually compared with unstimulated control cell lines. (c) Control
experiments. T-cell lines generated in the presence of Der p1 and Der p2, respectively, but negative in the re-stimulation assay were compared with unstimulated
control cell lines. *Po0.05 Wilcoxon-matched pairs test. Each group contained 9–17 patients.
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endotoxins, and other natural adjuvants
accompanying HDM allergens (Hammad
et al., 2009). In addition, the C-type lectin
receptor Dectin-2 on dendritic cells has
been recently reported to bind HDM
extracts and to signal toward Th2 and
Th17 in mice (Barrett et al., 2011; Parsons
et al., 2014).
In summary, we demonstrate that Der
p1– as well as Der p2–speciﬁc T cells
elicit a Th2/Th17-response in patients
with AD, although the allergens are
structurally and functionally different.
However, the existence of Th2, Th17,
and Th2/Th17 polarized HDM-speciﬁc
T cells in AD patients may indicate the
requirement for further disease-speciﬁc
anti-inﬂammatory treatment strategies.
New data provided here on the HDM-
speciﬁc T-cell response deserve atten-
tion, as they may help further optimize
speciﬁc immunotherapy in sensitized
patients suffering from AD. Of note,
combined use of Chipcytometry and
tetramer staining could serve as a
valuable diagnostic tool for interven-
tional studies. By this approach, new
details on the allergen-speciﬁc immune
response in relation to the clinical
course in patients with AD might be
identiﬁed in future.
All individuals included had given
their written consent. The study was
approved by the ethics committee of the
Hannover Medical School (MHH, No.
6117).
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